Physician profile
James A Field
NPI 1801896477
$2,274.53
in general payments reported to CMS, 2019-2025
19 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $409 · 2021: $380 · 2022: $477 · 2023: $226 · 2024: $252 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,125.91 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $250.56 | 2022-2025 | |
| Baxter Healthcare | $177.92 | 2020-2025 | Floseal, Tisseel |
| Davol INC. | $134.80 | 2020-2022 | |
| Medtronic, INC. | $129.60 | 2023-2025 | Endoflip, Sonicision, Progrip |
| Ethicon US, LLC | $93.19 | 2019-2024 | Stratafix, Ethicon |
| Allergan, INC. | $87.75 | 2021-2022 | |
| Apollo Endosurgery US INC | $34.48 | 2021 | |
| Wound Management Technologies, INC | $33.47 | 2019 | |
| Conmed Corporation | $28.19 | 2021 | |
| Avita Medical Americas, LLC | $26.32 | 2025 | Cohealyx, Recell, Permeaderm |
| Shionogi INC | $23.37 | 2023 | Fetroja |
| Teleflex LLC | $22.33 | 2021 | |
| Kci USA, INC. | $22.02 | 2021 | |
| Innovation Technologies INC | $17.98 | 2023 | Irrisept |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.55 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.86 | 2022 | |
| Innocoll Pharmaceuticals Limited | $16.28 | 2022 | |
| Tei Biosciences INC | $15.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.